Wuhan, China

Zilin Chen

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Scientific Methods, Inc., University of Notre Dame Du Lac. Active years: 2011.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zilin Chen: Innovator in Microbe Particle Capture Technology

Introduction

Zilin Chen is a notable inventor based in Wuhan, China. He has made significant contributions to the field of microbe particle capture technology. His innovative work has led to the development of methods and apparatus that enhance the efficiency of capturing and releasing microbe particles.

Latest Patents

Zilin Chen holds 1 patent for his invention titled "Methods and apparatus to capture and release microbe particles using amino-functionalized silica." This patent describes a unique apparatus designed to capture microbe particles, which includes a silica substrate coated with a positively charged material. The positively charged material features an aminopropyl functional group, which plays a crucial role in the capture process.

Career Highlights

Throughout his career, Zilin Chen has worked with esteemed institutions, including the University of Notre Dame Du Lac and Scientific Methods, Inc. His experience in these organizations has allowed him to refine his research and contribute to advancements in his field.

Collaborations

Zilin Chen has collaborated with notable colleagues such as Hsueh-Chia Chang and Fu-Chih Hsu. Their combined expertise has furthered the development of innovative solutions in microbe particle technology.

Conclusion

Zilin Chen's contributions to the field of microbe particle capture technology exemplify the impact of innovative thinking in scientific research. His work continues to influence advancements in this important area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…